×
neoBLUE LED Phototherapy System emits high-intensity blue LED light for the effective treatment of newborn jaundice, safely lowering the bilirubin levels in your young patient’s blood. Designed for efficiency and precision. Take the guessing out of positioning with our unique red target light, ensuring accurate light centering directly over the newborn.
Reduce costly and time-consuming bulb replacements with thousands of hours of use. Live testing has shown neoBLUE LEDs can emit high-intensity phototherapy for over 50,000 hours.
Safe by design
Safety always takes priority in newborn care. The neoBLUE LED Phototherapy System ensures intensive yet safe LED phototherapy with reduced risk of skin damage and water loss. neoBLUE LEDs do not emit significant light in the ultraviolet (UV) or infrared radiation (IR) ranges.
With a simple flip of a switch, change from standard (15 μW/cm2 /nm) to intensive (35 μW/cm2 /nm) phototherapy.
Intensity: Features two intensity settings to switch between standard (15 µW/cm²/nm) and intensive (35 µW/cm²/nm) phototherapy
Spectrum: Utilizes blue light emitting diodes (LEDs) to emit blue light in the 450-475 nm spectrum matching the peak absorption wavelength (458 nm) at which bilirubin is broken down2
Surface area coverage: Providing overhead light treatment to the newborn from head to toe
Resources and Support
Related Products
Contact
1 Subcommittee on Hyperbilirubinemia. American Academy of Pediatrics clinical practice guideline: Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004; 114(1):297-316.
2 Vreman HJ, et al. Light-emitting diodes: a novel light source for phototherapy. Pediatric Research. 1998; 44(5):804-809.
025121-001B
